A CLINICIAN'S GUIDE TO PROGRESSIVE SUPRANUCLEAR PALSY

A CLINICIAN'S GUIDE TO PROGRESSIVE SUPRANUCLEAR PALSY

Editorial:
RUTGERS UNIVERSITY PRESS
Año de edición:
Materia
Neurología
ISBN:
978-0-8135-6596-5
Páginas:
186
N. de edición:
1
Idioma:
Inglés
Disponibilidad:
Disponible en 2-3 semanas

Descuento:

-5%

Antes:

78,00 €

Despues:

74,10 €

1. History
2. Descriptive Epidemiology
3. Analytical Epidemiology
4. Clinical Rating Scales for PSP
5. The Clinical Spectrum of PSP
6. Differential Diagnosis
7. Diagnostic Criteria for PSP
8. Diagnosis of Early PSP
9. Cognitive and Behavioral Features
10. Eye movement
11. Dysarthria
12. Dysphagia
13. Physical and Occupational Therapy
14. Palliative care
15. Sleep
16. Imaging
17. Genetics
18. Drug Treatment for General and Motor Features
19. Emergency Management of PSP
20. Organization and Infrastructure of PSP Care
21. What's Coming?

This brief, clinically-focused volume is informed by Lawrence I. Golbe's three decades of research and tertiary clinical care in progressive supranuclear palsy, a complex disorder with rapidly changing diagnostic and therapeutic approaches. It is an ideal source for the general neurologist seeking a refresher and the primary care provider, neurological nurse, or physical, occupational or speech therapist who must address their patients' specialized needs.

A Clinician's Guide to Progressive Supranuclear Palsy emphasizes early diagnostic signs, medication options, non-pharmacologic management and palliative care. It offers a quick overview of the complications of PSP most likely to prompt an ER visit; a widening spectrum of PSP variants; and ample description of the genetics, epidemiology, natural history, pathology, molecular biology and neurochemistry of PSP. The PSP Rating Scale used in the book is a convenient tool for clinicians in routine practice and the leading PSP clinical measure world-wide. Golbe provides a practical and useful guidebook to help all clinicians learn and battle this complex disorder.

Author
Lawrence I. Golbe, MD is a professor of neurology at Rutgers Robert Wood Johnson Medical School in New Brunswick, New Jersey. He chairs the Scientific Advisory Board of CurePSP and serves as its Clinical Director. His research centers on the epidemiology, etiology, treatment and clinimetrics of PSP and Parkinson's disease.